254 related articles for article (PubMed ID: 2782112)
21. Polymyositis/dermatomyositis: clinical features and outcome in 22 patients.
Baron M; Small P
J Rheumatol; 1985 Apr; 12(2):283-6. PubMed ID: 3875720
[TBL] [Abstract][Full Text] [Related]
22. Cutaneous vasculitis in adult polymyositis/dermatomyositis.
Feldman D; Hochberg MC; Zizic TM; Stevens MB
J Rheumatol; 1983 Feb; 10(1):85-9. PubMed ID: 6842491
[TBL] [Abstract][Full Text] [Related]
23. Pulmonary involvement in polymyositis and in dermatomyositis.
Marie I; Hatron PY; Hachulla E; Wallaert B; Michon-Pasturel U; Devulder B
J Rheumatol; 1998 Jul; 25(7):1336-43. PubMed ID: 9676766
[TBL] [Abstract][Full Text] [Related]
24. Longterm survival and associated risk factors in patients with adult-onset idiopathic inflammatory myopathies and amyopathic dermatomyositis: experience in a single institute in Japan.
Yamasaki Y; Yamada H; Ohkubo M; Yamasaki M; Azuma K; Ogawa H; Mizushima M; Ozaki S
J Rheumatol; 2011 Aug; 38(8):1636-43. PubMed ID: 21572147
[TBL] [Abstract][Full Text] [Related]
25. Relationships between clinical features and distribution of mononuclear cells in muscle of patients with polymyositis.
Kalovidouris AE; Stoesz E; Muller J; Kimes T; Brandt KD
J Rheumatol; 1988 Sep; 15(9):1401-6. PubMed ID: 3199400
[TBL] [Abstract][Full Text] [Related]
26. Retrospective study of polymyositis in Auckland over 10 years.
Ogle S
N Z Med J; 1980 Dec; 92(673):433-5. PubMed ID: 6937784
[TBL] [Abstract][Full Text] [Related]
27. Relationship between serum creatine kinase level and corticosteroid therapy in polymyositis-dermatomyositis.
Oddis CV; Medsger TA
J Rheumatol; 1988; 15(5):807-11. PubMed ID: 3172094
[TBL] [Abstract][Full Text] [Related]
28. Differences in clinical features and prognosis of interstitial lung diseases between polymyositis and dermatomyositis.
Fujisawa T; Suda T; Nakamura Y; Enomoto N; Ide K; Toyoshima M; Uchiyama H; Tamura R; Ida M; Yagi T; Yasuda K; Genma H; Hayakawa H; Chida K; Nakamura H
J Rheumatol; 2005 Jan; 32(1):58-64. PubMed ID: 15630726
[TBL] [Abstract][Full Text] [Related]
29. Combination therapy with corticosteroids, cyclosporin A, and intravenous pulse cyclophosphamide for acute/subacute interstitial pneumonia in patients with dermatomyositis.
Kameda H; Nagasawa H; Ogawa H; Sekiguchi N; Takei H; Tokuhira M; Amano K; Takeuchi T
J Rheumatol; 2005 Sep; 32(9):1719-26. PubMed ID: 16142867
[TBL] [Abstract][Full Text] [Related]
30. Polymyositis-dermatomyositis:25 years of follow-up of 50 patients disease course, treatment, prognostic factors.
Chwalińska-Sadowska H; Małdykowa H
Mater Med Pol; 1990; 22(3):213-8. PubMed ID: 2132429
[TBL] [Abstract][Full Text] [Related]
31. Intravenous immunoglobulins for steroid-refractory esophageal involvement related to polymyositis and dermatomyositis: a series of 73 patients.
Marie I; Menard JF; Hatron PY; Hachulla E; Mouthon L; Tiev K; Ducrotte P; Cherin P
Arthritis Care Res (Hoboken); 2010 Dec; 62(12):1748-55. PubMed ID: 20722047
[TBL] [Abstract][Full Text] [Related]
32. Interstitial lung disease in polymyositis and dermatomyositis.
Marie I; Hachulla E; Chérin P; Dominique S; Hatron PY; Hellot MF; Devulder B; Herson S; Levesque H; Courtois H
Arthritis Rheum; 2002 Dec; 47(6):614-22. PubMed ID: 12522835
[TBL] [Abstract][Full Text] [Related]
33. Histopathology of Gottron's papules--utility in diagnosing dermatomyositis.
Mendese G; Mahalingam M
J Cutan Pathol; 2007 Oct; 34(10):793-6. PubMed ID: 17880586
[TBL] [Abstract][Full Text] [Related]
34. Risk of cancer in patients with dermatomyositis or polymyositis, and follow-up implications: a Scottish population-based cohort study.
Stockton D; Doherty VR; Brewster DH
Br J Cancer; 2001 Jul; 85(1):41-5. PubMed ID: 11437400
[TBL] [Abstract][Full Text] [Related]
35. Clinical profile of polymyositis in Kashmir valley.
Shah PA; Hassan I; Choudhary ND; Nafae A
J Assoc Physicians India; 1999 May; 47(5):480-2. PubMed ID: 10778554
[TBL] [Abstract][Full Text] [Related]
36. [Predictive factors and unfavorable prognostic factorial analysis of interstitial lung disease in patients with inflammatory myopathy].
Li R; Li XP; Li XM; Wang GS; Qian L; Tao JH; Ma Y; Zhang H
Zhonghua Yi Xue Za Zhi; 2012 Sep; 92(33):2335-8. PubMed ID: 23158563
[TBL] [Abstract][Full Text] [Related]
37. Dermatomyositis and polymyositis associated with malignancy: a 21-year retrospective study.
András C; Ponyi A; Constantin T; Csiki Z; Szekanecz E; Szodoray P; Dankó K
J Rheumatol; 2008 Mar; 35(3):438-44. PubMed ID: 18203322
[TBL] [Abstract][Full Text] [Related]
38. [Polymyositis, dermatomyositis and inclusion body myositis, nosological aspects].
Eymard B
Presse Med; 2003 Oct; 32(35):1656-67. PubMed ID: 14631270
[TBL] [Abstract][Full Text] [Related]
39. Relationship of cancer to inflammatory muscle diseases. Dermatomyositis, polymyositis, and inclusion body myositis.
Callen JP
Rheum Dis Clin North Am; 1994 Nov; 20(4):943-53. PubMed ID: 7855330
[TBL] [Abstract][Full Text] [Related]
40. Juvenile dermatomyositis and polymyositis.
Pachman LM; Maryjowski MC
Clin Rheum Dis; 1984 Apr; 10(1):95-115. PubMed ID: 6734123
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
